hereditary cancer Mar 24, 2021 Intermountain Gets National Stage, Myriad Adds Tumor Profiling Panel With Combined Test Offering Premium Feb 23, 2021 German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing Premium Sep 10, 2020 NCCN Updates Guidelines Advising Against Using Polygenic Risk Scores Outside of Clinical Trials Jul 17, 2020 BRCA1/2 Population Screening Predicted to be Cost-Effective in Countries With Different Income Levels Jul 14, 2020 Piper Sandler Initiates Coverage of Progenity With Overweight Rating Jun 18, 2020 Promega Maintains Microsatellite Instability IVD Plans Amid Evolving Cancer Test Landscape May 21, 2020 Q&A: ACMG Work Group Hoping to Spark Discussion on Reporting Germline Findings From Tumor Testing Apr 6, 2020 Myriad Genetics BRCA Test to be Reimbursed in Japan Mar 6, 2020 Ambry Genetics +RNA Insight Validation Data Suggests Notable Improvement in Diagnostic Yield Premium Feb 6, 2020 Myriad Genetics Q2 Revenues Decrease 10 Percent; CEO Mark Capone Steps Down Feb 6, 2020 Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing Nov 21, 2019 Myriad Genetics BRACAnalysis Approved by Japanese Regulators Nov 6, 2019 Invitae Q3 Revenues Grow 51 Percent Nov 4, 2019 Myriad Genetics Fiscal Q1 Revenues Drop 8 Percent on Hereditary Cancer Testing Coding Challenges Oct 30, 2019 CMS Proposes New National Coverage Policy for NGS Germline Testing Oct 18, 2019 Color, Ochsner Health System Collaborating on Population Health Pilot Oct 4, 2019 Adding RNA-Seq, Ambry Genetics Expects to Reduce VUS Results in Hereditary Cancer Tests Premium Sep 30, 2019 Lucence Diagnostics Singapore Lab Receives CLIA Certification Sep 5, 2019 Large-Scale Multigene Panel Study of Hereditary Cancer Risk Refines Gene Associations Premium Apr 8, 2019 Expanded Germline Panel Testing in Cancer Patients Catches Risk Variants Missed by Focused Tests Load More Breaking News European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal AnPac Bio to Raise $5M in Private Placement Top Five Articles on 360Dx Last Week: Sherlock Bio's $2M Award; Nostics' POC Testing Plans; and More KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
